Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials-Reference-Cited by-同舟云学术

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials

Published:2017-06 Issue:6 Volume:5 Page:431-437
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Zoungas Sophia,Arima Hisatomi,Gerstein Hertzel C,Holman Rury R,Woodward Mark,Reaven Peter,Hayward Rodney A,Craven Timothy,Coleman Ruth L,Chalmers John

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Health and Medical Research Council of Australia

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference18 articles.

1. IDF diabetes atlas,2015

2. Changes in diabetes-related complications in the United States, 1990–2010;Gregg;N Engl J Med,2014

3. Need for better diabetes treatment for improved renal outcome;Rossing;Kidney Int,2011

4. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials;Boussageon;BMJ,2011

5. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials;Hemmingsen;BMJ,2011

Cited by 408 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Exposure As a Predictor in Diabetic Retinopathy Risk Prediction Models—A Systematic Review and Meta-Analysis;American Journal of Ophthalmology;2024-12

2. Glycemic Control and Retinal Microvascular Changes in Type 2 Diabetes Mellitus Patients without Clinical Retinopathy;Diabetes & Metabolism Journal;2024-09-30

3. Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis;Expert Review of Clinical Pharmacology;2024-09-11

4. Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care;Biomedicines;2024-09-07

5. Utilization and cost of non‐insulin glucose‐lowering drugs in Australia from 2013 to 2023;Diabetes, Obesity and Metabolism;2024-09-02